Figure S1 (a). Flowchart for selection of DR cases for marker selection. Figure S1 (b) . Flowchart for selection of cohort cases with rapid renal function decline for replication. Figure S2 (a) . First two components (C1 and C2) of multidimensional scaling (MDS) plot. Our sample (OWN, black, crosses) is clearly separated from the 1000 Genomes Project reference population, including European (EUR, light green, square), Ad-Mixed American (AMR, pink, triangle), and African (AFR, blue, diamond). As expected, our sample colocalizes with East Asian (EAS, red, circle). † represents a P value less than 0.05. ‡ represents a P value less than 0.001. ERFD, early renal functional decline; OR, odds ratio; CI, confidence interval; Q, quantile; Ref., reference. Early renal function decline was defined as more than 3.3 mL/min per 1.73 m 2 decline in the eGFR per year. The genetic risk score was calculated based on 3 SNPs listed on Table S6 .
† represents a P value less than 0.05. ‡ represents a P value less than 0.001. eGFR, estimated glomerular filtration rate; β:unstandardized coefficient; S.E., standard error; CI, confidence interval; BMI, body mass index; HDL: high density lipoprotein; LDL: low density lipoprotein; ACR: urine albumin creatinine ratio. The genetic risk score was calculated based on 33 SNPs listed on Table S5 .
† represents a P value less than 0.05. ‡ represents a P value less than 0.001.
